Seth Van-Voorhees Insider Profile
4 Followers
Seth Van-Voorhees, CFO at NRX Pharmaceuticals, holds 46.34K shares in NRX Pharmaceuticals (Ticker: NRXP), holds 17.65K shares in PDS Biotechnology (Ticker: PDSB), holds 230.45K shares in Research Frontiers (Ticker: REFR). Most recently, Seth Van-Voorhees Bought ― shares of NRX Pharmaceuticals on Dec 19, 2022 for an estimated value of $33.00K.
Seth Van-Voorhees's Trading History
You May Also Like
Seth Van-Voorhees insider profile FAQ
What is the percentage of profitable transactions made by Seth Van-Voorhees?
The percentage of profitable transactions made by Seth Van-Voorhees is 50%.
What is the average return per transaction made by Seth Van-Voorhees?
The average return per transaction made by Seth Van-Voorhees is -25.20%.
What stocks does Seth Van-Voorhees hold?
Seth Van-Voorhees holds: NRXP, REFR, PDSB, APFC stocks.
What was Seth Van-Voorhees’s latest transaction?
Seth Van-Voorhees’s latest transaction was an Informative Buy of $33.00K.
What was Seth Van-Voorhees's most profitable transaction?
Seth Van-Voorhees’s most profitable transaction was an Informative Buy of REFR stock on September 13, 2017. The return on the trade was 23.20%.
What is Seth Van-Voorhees's role in NRX Pharmaceuticals?
Seth Van-Voorhees's role in NRX Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
